Evidence map›Paper›PMID 25149223›Full record

ReviewLancet (London, England)2015

Maternal and neonatal tetanus.

C Louise Thwaites, Nicholas J Beeching, Charles R Newton

Registry-linked trialAbstract readReview
In one paragraph

Review in Lancet (London, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02999815 (Intrathecal Immunoglobulin for Treatment of Adult Patients With Tetanus), which is not on this map. Cited by 95 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02999815 phase1 / phase2completednot on this mapstarted 2017, after this paper: background citation

Intrathecal Immunoglobulin for Treatment of Adult Patients With Tetanus: a Randomized Controlled 2x2 Factorial Trial

TypeinterventionalSponsorOxford University Clinical Research Unit, VietnamRan2017 to 2020Enrolled272ConditionsTetanusArmsHuman tetanus immunoglobulin, Intramuscular antitoxin
3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Breastfeeding and the Risk of Infant Illness in Asia: A Review.International journal of environmental research and public health · 2019
    Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Tetanus: recognition and management.The Lancet. Infectious diseases · 2025
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

C Louise ThwaitesOxford University Clinical Research Unit, Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam. Electronic address: lthwaites@oucru.org.
Nicholas J BeechingLiverpool School of Tropical Medicine, and Tropical and Infectious Disease Unit, Royal Liverpool University Hospital, and National Institute for Health Research Health Protection Research Unit in Emerging and Zoonotic Infections, Liverpool, UK.
Charles R NewtonKenya Medical Research Institute - Wellcome Trust Collaborative Programme, Kilifi, Kenya; Department of Psychiatry, University of Oxford, Oxford, UK.

Funding

Wellcome Trust 089276Wellcome Trust 092654
6 · The paper itself

Abstract

Maternal and neonatal tetanus is still a substantial but preventable cause of mortality in many developing countries. Case fatality from these diseases remains high and treatment is limited by scarcity of resources and effective drug treatments. The Maternal and Neonatal Tetanus Elimination Initiative, launched by WHO and its partners, has made substantial progress in eliminating maternal and neonatal tetanus. Sustained emphasis on improvement of vaccination coverage, birth hygiene, and surveillance, with specific approaches in high-risk areas, has meant that the incidence of the disease continues to fall. Despite this progress, an estimated 58,000 neonates and an unknown number of mothers die every year from tetanus. As of June, 2014, 24 countries are still to eliminate the disease. Maintenance of elimination needs ongoing vaccination programmes and improved public health infrastructure.

Indexed as

Abortion, InducedAnti-Bacterial AgentsDisease EradicationFemaleGlobal HealthHumansInfantInfant MortalityInfant, NewbornMaternal MortalityPregnancyPregnancy Complications, InfectiousTetanusTetanus AntitoxinTetanus ToxinAnti-Bacterial AgentsTetanus AntitoxinTetanus Toxin

Identifiers

PMID25149223
PMCPMC5496662

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.